Clinical Updates
Drug approvals, guideline changes, and treatment advances
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Clinical Updates
Ebola Recoveries Offer Clinical and Public Health Insights Amid DRC Outbreak
Documented recoveries from Ebola virus disease in the Democratic Republic of Congo outbreak provide critical…
Adaptive Deep Brain Stimulation Restores Walking in Parkinson’s Disease: Nature Medicine Study
A new study in Nature Medicine demonstrates that deep brain stimulation devices using real-time neural…
Brain-Computer Interface Restores Speech in ALS Patient After Two Years of Home Use
A person with ALS used an implanted brain-computer interface to restore speech and computer control…
Oral GLP-1 medication shows major promise for type 2 diabetes: weight loss and blood sugar control in pivotal trial
A pivotal clinical trial demonstrates that a new oral GLP-1 medication achieves substantial improvements in…
High Tyrosine Levels Linked to Reduced Life Expectancy in Men, Large Study Suggests
A large-scale epidemiological study has found that men with higher circulating levels of tyrosine—a common…